Skip to main content
OpenTrials

Clinical trial condition

Peanut Allergy

Explore clinical trials studying Peanut Allergy. Study availability and eligibility vary by location and protocol.

76 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Peanut Allergy trial results

Completed

Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)

NCT03292484

Conditions
Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +4 more
Locations
  • Alabama Allergy and Asthma Center Birmingham, Alabama, United States
  • Medical Research of Arizona, Allergy, Asthma & Immunology Associates Scottsdale, Arizona, United States
  • Banner Univ. of Arizona Medical Center Tucson, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 93 locations
View Trial Details
Completed

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age

NCT03211247

Conditions
Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +4 more
Locations
  • University of Arizona Health Science Tucson, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of California School of Medicine Los Angeles, California, United States
  • University of California, Rady Children's Hospital San Diego, California, United States
View all 51 locations
View Trial Details
Completed

A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine

NCT02851277

Conditions
Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +4 more
Locations
  • Site US10014 Little Rock, Arkansas, United States
  • Site US10008 Mountain View, California, United States
  • Site US10001 Baltimore, Maryland, United States
  • Site US10002 Boston, Massachusetts, United States
View Trial Details
Completed

A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine

NCT03755713

Conditions
Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +4 more
Locations
  • Arkansas Children's Hospital Research Institute Little Rock, Arkansas, United States
  • Sean N Parker Center for Allergy & Asthma Research, LPCH El Camino Hospital Mountain View, California, United States
  • The University of Chicago Medicine Chicago, Illinois, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)

NCT03682770

Conditions
Food Hypersensitivity, Hypersensitivity, Hypersensitivity, Immediate, +4 more
Locations
  • Regeneron Investigational Site Birmingham, Alabama, United States
  • Regeneron Investigational Site Tucson, Arizona, United States
  • Regeneron Investigational Site Little Rock, Arkansas, United States
  • Regeneron Investigational Site Los Angeles, California, United States
View all 25 locations
View Trial Details

Related conditions